The addictive protection against SARS-CoV-2 reinfection conferred by vaccination, as
compared to natural immunity alone, remains to be quantified. We thus carried out a meta …

Aim: Global expenditure on medicines is rising up to 6% per year driven by increasing
prevalence of non-communicable diseases (NCDs) and new premium priced medicines for …

Abstract The Rotterdam Study is a prospective cohort study ongoing since 1990 in the city of
Rotterdam in The Netherlands. The study targets cardiovascular, endocrine, hepatic …

Objective It has been hypothesised that the use of ACE inhibitors and angiotensin receptor
blockers (ARBs) might either increase or reduce the risk of severe or lethal COVID-19. The …

The cost of prescription drugs in the United States continues to be a source of concern for
patients, caregivers, and policymakers. Drug prices typically decline rapidly once generic …

The prescription of generic drugs represents one of the main cost-containment strategies of
health systems, aimed at reducing pharmaceutical expenditure. In this context, most …

Objective: Global expenditure on medicines is increasing driven by a number of factors.
These include the launch of new premium-priced medicines for complex diseases including …

Increasing prescription drug expenditures in the United States are primarily driven by high
brand-name drug prices. Although generic competition helps lower drug prices …

Generic medications offer substantial potential cost savings to health systems compared to
their branded counterparts. In Europe and the US, they are only approved if they are …

Background: Prescribing of lipid-lowering agents (LLAs) has increased worldwide including
in Scotland with increasing prevalence of coronary heart disease, and higher dose statins …